Gold(I)-catalyzed intramolecular hydroarylation and the subsequent ring enlargement of methylenecyclopropanes to cyclobutenes

Wei Fanga, Xiang-Ying Tangb and Min Shi*ab
aKey Laboratory for Advanced Materials and Institute of Fine Chemicals, East China University of Science and Technology, Meilong Road No. 130, Shanghai, 200237, China
bState Key Laboratory of Organometallic Chemistry, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, 354 Fenglin Lu, Shanghai 200032, China. E-mail: mshi@mail.sioc.ac.cn; Fax: +86-21-64166128

Received 28th January 2016 , Accepted 1st April 2016

First published on 6th April 2016


Abstract

The gold(I)-catalyzed intramolecular hydroarylation of methylenecyclopropanes containing aryl propargyl ethers proceeded smoothly to give 2H-chromene derivatives in good to excellent yields under mild conditions. Furthermore, in the presence of IPrAuSbF6, these 2H-chromene derivatives containing a methylenecyclopropane could undergo ring enlargement to give the corresponding cyclobutenes.


The metal-catalyzed hydroarylation of alkynes has long been recognized as an effective approach to synthesize 2H-chromene derivatives by 6-endo dig cyclization as chromenes, chromanes, coumarins and related heterocycles are key sections of structures in many natural products.1 Since the intramolecular hydroarylation of substituted aryl propargyl ethers was first reported by Iwai et al. in 1963,2 the transformation methods have been extensively investigated, with most of them were carried out under extremely harsh conditions, such as at high temperatures, even up to 200 °C. Afterwards, some metal-catalysts, such as Pd, Pt, Hg, Ag, Ru, Rh, In, Re, etc.3 including Au,4 were applied to facilitate this reaction (Scheme 1). The use of metal-catalysts allowed this reaction to proceed smoothly under milder conditions.
image file: c6ra02549h-s1.tif
Scheme 1 Previous work and this work.

Methylenecyclopropanes (MCPs), as an easily available class of substrates with an exceedingly high ring strain, have served as useful building blocks in organic synthesis owing to their unique structure and electronic properties.5 In the past decade, the ring-opening functionalizations of methylenecyclopropanes have been extensively investigated under transition metal catalysis6 and Lewis acid catalysis.7 Ring enlargement of the methylenecyclopropanes to cyclobutenes is readily driven by release of the ring tension. This kind of rearrangement was reported by Fürstner8 and Shi9 (Scheme 1). Cyclobutenes are useful intermediates for organic synthesis, and are widely found as important structural motifs in an abundant number of biologically active molecules.10 However, few strategies have been disclosed to synthesize cyclobutenes, suggesting that the further development of new synthetic methods is highly desirable.

Concerning the previous studies, we successfully prepared a class of substituted ortho-(propargyloxy)aryl methylenecyclopropanes 1 and investigated their cyclization in the presence of a suitable gold complex. In this paper, we wish to report the intramolecular hydroarylation of 1 to give 2H-chromene and the simultaneous ring enlargement of methylenecyclopropane to cyclobutenes in the presence of gold(I) catalysts in 1,2-dichloroethane (DCE) (Scheme 1).

We initially attempted to optimize the reaction conditions for these transformations using 1a as a model substrate and the results are summarized in Table 1. As can be seen from Table 1, compound 2a was given in a 65% yield at room temperature within 5 hours in the presence of JohnPhosAuSbF6 (2.5 mol%) in 1,2-dichloroethane (DCE) (Table 1, entry 1). Pt(cod)Cl2 and Ph3PAuCl/AgSbF6 did not catalyze this reaction at room temperature (Table 1, entries 2 and 3). When (p-CF3C6H4)3PAuSbF6 (2.5 mol%) was used as the catalyst, compound 2a was formed in an 86% yield at room temperature within 3 hours in DCE (Table 1, entry 4). With PtCl2/CO or Rh(PPh3)3Cl as the catalyst, 2a was produced in moderate yields at 60 °C and 80 °C, respectively (Table 1, entries 5 and 6). By changing the reaction temperature in the presence of JohnPhosAuSbF6, 2a and cyclobutene 3a were produced in 30% and 35% yields, respectively, at 80 °C, and 3a was afforded in an 83% yield as the sole product at 90 °C within 12 hours in DCE (Table 1, entries 7 and 8). When the counter ion of the gold complex was changed to trifluoromethanesulfonate, 2a was only given in a lower yield at 90 °C in DCE (Table 1, entries 9–11). None of the desired product was given in the presence of t-BuXPhosAuCl/AgSbF6 at 90 °C in DCE (Table 1, entry 12). Using PPh3AuSbF6 and Cy–JohnPhosAuSbF6 as the catalysts gave 2a in 48% and 80% yields, respectively, at 90 °C in DCE (Table 1, entries 13 and 14). In the presence of sterically bulky phosphine coordinated gold complexes, such as t-BuXPhosAuSbF6 or Me4-t-BuXPhosAuSbF6, compound 3a was obtained as the sole product, but in a low yield at 90 °C in DCE (Table 1, entries 15 and 16). Using the electron-deficient phosphine coordinated gold complex (C6F5)3PAuSbF6 as the catalyst gave no desired product at 90 °C in DCE (Table 1, entry 17). However, compound 3a was exclusively produced in a 94% yield in the presence of the electron-rich gold complex IPrAuSbF6 (IPr: 1,3-bis(2,6-diisopropylphenyl)-2,3-dihydro-1H-imidazole, Scheme 1) at 90 °C within 4 hours in DCE (Table 1, entry 18). Then, we screened the solvent for this reaction, and 69, 76, and 60% yields for 3a were given at 90 °C within 4 hours in toluene, 1,4-dioxane and nitroethane, respectively (Table 1, entries 19–21).

Table 1 Optimization of the reaction conditionsa

image file: c6ra02549h-u1.tif

Entry Catalyst Solvent Temp. (°C) Time (h) Conv. (%) Yield (%)
2a 3a
a Reaction conditions: 1a (0.2 mmol), catalyst (2.5 mol%), solvent (2.0 mL), isolated yields.b Yields were determined by 1H NMR spectroscopy.
1 JohnPhosAuSbF6 DCE rt 5 >99 65
2 Pt(cod)Cl2 DCE rt 24 <5
3 PPh3AuCl/AgSbF6 DCE rt 0.5 >99
4 (p-CF3C6H4)3PAuSbF6 DCE rt 3 >99 86
5 PtCl2/CO (1 atm) DCE 60 24 >99 50b  
6 Rh(PPh3)3Cl DCE 80 12 94 43
7 JohnPhosAuSbF6 DCE 80 12 >99 30 35
8 JohnPhosAuSbF6 DCE 90 12 >99 83
9 JohnPhosAuCl/AgOTf DCE 90 3 >99 13
10 t-BuXPhosAuOTf DCE 90 5 >99 39  
11 XPhosAuOTf DCE 90 12 >99 41
12 t-BuXPhosAuCl/AgSbF6 DCE 90 0.5 >99
13 PPh3AuSbF6 DCE 90 4 >99 48b
14 Cy–JohnPhosAuSbF6 DCE 90 10 >99 80b
15 t-BuXPhosAuSbF6 DCE 90 4 84 16b
16 Me4-t-BuXPhosAuSbF6 DCE 90 10 >99 21b
17 (C6F5)3PAuSbF6 DCE 90 4 >99
18 IPrAuSbF6 DCE 90 4 >99 94
19 IPrAuSbF6 Toluene 90 4 >99 69b
20 IPrAuSbF6 Dioxane 90 4 >99 76b
21 IPrAuSbF6 EtNO2 90 4 >99 60b


Having the optimal reaction conditions in hand, we next examined the scope of the reaction with respect to various substituted ortho-(propargyloxy)aryl methylenecyclopropanes 1. The results of these experiments are shown in Table 2. To vary the substituents at the benzene ring, no remarkable alteration in regard to the yield of 2 was observed when methyl or halogen atoms, such as F, Cl or Br, were introduced at the benzene ring. The position of the substituent at the benzene ring also had some impacts on the yield of 2. For instance, the yield of 2e was higher than that of 2h. The disparity in yield was because of the different electronic effect of the aromatic ring. Substituent Cl in 1h, as an electron-withdrawing group, reduced the electron density at C3, thereby disfavouring the intramolecular hydroarylation (Table 2, entries 5 and 8). When NO2 was introduced at the benzene ring, the reaction could not take place, presumably due to its strongly electron-withdrawing effect (Table 2, entry 9). When the substituent was a MeO group at the benzene ring, complex products were afforded as a result of a strongly electron-donating effect (Table 2, entry 10). When R2 was a phenyl group, the corresponding product 2g was formed in an 83% yield. However, when R2 was CO2Et, the reaction gave a complex product mixture (Table 2, entry 11).

Table 2 Substrate scope of substituted ortho-(propargyloxy)aryl methylenecyclopropanes 1 to products 2a

image file: c6ra02549h-u2.tif

Entry R1, R2 Yield (%)
a Reactions were carried out using MCP 1 (0.2 mmol) in 1,2-dichloroethane (DCE) (2.0 mL) with (p-CF3C6H4)3PAuSbF6 (4.5 mg, 2.5 mol%), isolated yields.b Reaction time was 6 hours. N.R. means no reaction.
1 1a, R1 = H, R2 = H 2a, 86
2 1b, R1 = 5-Me, R2 = H 2b, 78
3 1c, R1 = 4-Me, R2 = H 2c, 73b
4 1d, R1 = 5-F, R2 = H 2d, 80
5 1e, R1 = 5-Cl, R2 = H 2e, 95
6 1f, R1 = 5-Br, R2 = H 2f, 64
7 1g, R1 = H, R2 = Ph 2g, 83b
8 1h, R1 = 4-Cl, R2 = H 2h, 61
9 1i, R1 = 5-NO2, R2 = H N.R.
10 1j, R1 = 4-MeO, R2 = H Complex
11 1k, R1 = H, R2 = CO2Et Complex


Next, we explored the generality for the production of cyclobutenes 3 under the optimal conditions, and the results are shown in Table 3. Substrates 1b–f and 1h bearing methyl and different halogen atoms, such as F, Cl or Br, at the benzene ring resulted in the formation of 3b–f and 3h in 41–64% yields. The influence of the substituent and its position was also observed. For example, introducing a Me at the ortho-position of the benzene ring as an electron-donating group increased the electron density of C3, favouring the intramolecular hydroarylation, to give 3c in a higher yield than that of 3b (Table 3, entries 2 and 3). As for substrate 1h bearing a Cl atom at the ortho-position, the electron density of C3 was reduced, giving 3h in a lower yield than that of 3e (Table 3, entries 5 and 8). As for substrate 1g, in which a phenyl group was introduced at the terminal alkyne, the expected product 3g could be also given, resulting in a 76% yield. Using 1i, 1j and 1k as the substrates, all afforded complex product mixtures, perhaps due to the electronic effect (Table 3, entries 9–11) (Scheme 2).

Table 3 Substrate scope of substituted ortho-(propargyloxy)aryl methylenecyclopropanes 1 to products 3a

image file: c6ra02549h-u3.tif

Entry R1, R2 Yield (%)
a Reactions were carried out using MCP 1 (0.2 mmol) in 1,2-dichloroethane (DCE) (2.0 mL) with IPrAuSbF6 (4.0 mg, 2.5 mol%), isolated yields.b Reaction time was 10 hours.c Reaction time was 0.5 hour.
1 1a, R1 = H, R2 = H 3a, 94
2 1b, R1 = 5-Me, R2 = H 3b, 45
3 1c, R1 = 4-Me, R2 = H 3c, 63b
4 1d, R1 = 5-F, R2 = H 3d, 41
5 1e, R1 = 5-Cl, R2 = H 3e, 64
6 1f, R1 = 5-Br, R2 = H 3f, 64
7 1g, R1 = H, R2 = Ph 3g, 76
8 1h, R1 = 4-Cl, R2 = H 3h, 46
9 1i, R1 = 5-NO2, R2 = H Complex
10 1j, R1 = 4-MeO, R2 = H Complexc
11 1k, R1 = H, R2 = CO2Et Complex



image file: c6ra02549h-s2.tif
Scheme 2 Reaction of methylenecyclobutanes 1l–1m.

Furthermore, we prepared ortho-(propargyloxy)aryl methylenecyclobutanes 1l–m, and carried out the reactions under the same conditions. We found that using methylenecyclobutane to replace methylenecyclopropane produced the corresponding product 2l in only a 33% yield, along with some unidentified product complexes, presumably due to the fact that methylenecyclobutane does not have a higher strain energy as that of methylenecyclopropane.11 Thus, its double bond can act the same as one in a normal olefinic compound, causing the production of some other byproducts. However, when a phenyl group was introduced at the terminal alkyne, the desired product 2m could also be obtained in an 80% yield, perhaps due to the phenyl being able to stabilize the in situ generated vinyl carbocation after gold(I) catalyst binding to the alkyne, as shown in Scheme 4, thus facilitating the intramolecular hydroarylation. The corresponding compounds 3l and 3m could not be obtained from the reactions of 1l and 1m under the standard conditions, probably due to the lower strain energy of methylenecyclobutane, compared with that of methylenecyclopropane.

A control experiment was conducted using 2a as the starting material, giving 3a in an 83% yield in the presence of IPrAuSbF6 (2.5 mol%) in DCE at 90 °C, suggesting that 3a is derived from 2a under gold catalysis. In addition, no reaction occurred in the absence of gold catalyst (Scheme 3).


image file: c6ra02549h-s3.tif
Scheme 3 Compound 2a was converted into product 3a upon addition of a gold catalyst in contrast to the reaction with no catalyst.

Based on Fürstner's7,8 previous report and other groups' work,12 a plausible mechanism for these reactions is depicted in Scheme 4. The initial species is the formation of a cyclized Au complex IM-I, generated likely through two paths: path (a) and path (b). Path (a) involves the gold(I) catalyst directly coordinating with the triple bond of the propargyl moiety in 1a, while path (b) involves the triple bond first binding covalently with the gold(I) catalyst, followed by the gold(I) catalyst coordinating with the double bond in the benzene ring. Then, through protonation, product 2a is produced and the gold(I) catalyst is regenerated at the same time if the employed catalyst is (p-CF3C6H4)3PAuSbF6. Furthermore, the gold(I) catalyst can next coordinate to the double bond of MCP to produce a stabilized cyclopropylmethyl cation IM-II 13 which is a nonclassical carbocationic intermediate in the presence of IPrAuSbF6. This carbocationic species is apt to rearrange to the corresponding cyclobutenyl cation IM-III, likely bearing some carbene character, and then gives the final product after a 1,2-hydrogen shift.7 The ligand in the gold catalyst plays an important role in controlling the reaction process that furnished the different products. Electron-poor phosphine ligands, such as (p-CF3C6H4)3P, produced the vinyl gold specie IM-I, which has a higher stability towards protodeauration; also after the protodeauration of the catalyst, it was more difficult to activate the double bond of methylenecyclopropanes than the triple bond of alkynes. Thus, the reaction was terminated by compound 2a.14 Electron-rich NHC ligands, such as IPr (1,3-bis(2,6-diisopropylphenyl)-2,3-dihydro-1H-imidazole), favoured protodeauration, and the regenerated cationic gold catalyst swiftly activated the double bond of methylenecyclopropane to afford the final product 3a.14


image file: c6ra02549h-s4.tif
Scheme 4 Proposed mechanisms.

In conclusion, we developed gold(I)-catalyzed substituted aryl propargyl ethers to effectively produce 2H-chromene derivatives through intramolecular hydroarylation in good to excellent yields. Simultaneously, we also demonstrated that the further transformation of 2H-chromene derivatives containing a methylenecyclopropane moiety was possible to attain cyclobutenes through ring enlargement of the methylenecyclopropanes under gold(I) catalysis using IPrAuSbF6 as the catalyst, which is another effective method to synthesize cyclobutene. Further investigations on this and related transition metal-catalyzed hydroarylations and further transformations are ongoing.

Experimental section

Compound 2a

To a flame-dried flask were added methylenecyclopropane 1a (37 mg, 0.2 mmol, 1.0 equiv.) and (p-CF3C6H4)3PAuSbF6 (0.005 mmol, 0.025 equiv.). The flask was evacuated and backfilled with Ar, with this process carried out a total of three times. DCE (2.0 mL) was then added to this flask via a syringe under Ar. The reaction mixture was stirred for 3 hours at room temperature. An appropriate amount of silica gel was added to the reaction mixture and the solvent was removed under vacuum pump at low temperature; finally, the crude product was purified by silica gel chromatography (PE) to obtain the desired product 2a (32 mg, 86%) as a colourless oil. 1H NMR (CDCl3, 400 MHz, TMS) δ 1.14–1.18 (m, 2H, CH2), 1.36–1.40 (m, 2H, CH2), 4.85 (dd, J1 = 3.6 Hz, J2 = 2.0 Hz, 2H, CH2), 5.79 (dt, J1 = 9.6 Hz, J2 = 3.6 Hz, 1H, [double bond, length as m-dash]CH), 6.42 (d, J = 9.6 Hz, 1H, [double bond, length as m-dash]CH), 6.83–6.84 (m, 2H, Ar), 7.05 (s, 1H, [double bond, length as m-dash]CH), 7.58 (dd, J1 = 4.8 Hz, J2 = 4.8 Hz, 1H, Ar). 13C NMR (CDCl3, 100 MHz, TMS) δ 0.6, 3.9, 65.5, 111.6, 120.9, 121.8, 122.5, 124.5, 124.9, 125.0, 125.7, 126.3, 150.5. IR (neat) ν 3291, 3046, 2972, 2846, 2123, 1784, 1638, 1581, 1460, 1323, 1237, 1199, 1086, 975, 745 cm−1. MS (%) m/z 184 (M+, 84.89), 183 (100.00), 169 (34.64), 155 (37.71), 141 (35.89), 128 (37.02), 115 (56.60), 91 (24.40), 51 (16.02). HRMS (EI) calcd for C13H12O: 184.0888, found: 184.0886.

Compound 3a

To a flame-dried flask were added methylenecyclopropane 1a (37 mg, 0.2 mmol, 1.0 equiv.) and IPrAuSbF6 (0.005 mmol, 0.025 equiv.). The flask was evacuated and backfilled with Ar, with this process carried out a total of three times. DCE (2.0 mL) was added to this flask via a syringe under Ar. The reaction mixture was stirred for 4 hours at 90 °C. An appropriate amount of silica gel was added to the reaction mixture and the solvent was removed under vacuum pump at low temperature; finally, the crude product was purified by silica gel chromatography (PE) to obtain the desired product 3a. (35 mg, 94%) as a colourless oil. 1H NMR (CDCl3, 400 MHz, TMS) δ 2.55–2.57 (m, 2H, CH2), 2.82–2.83 (m, 2H, CH2), 4.88 (dd, J1 = 3.6 Hz, J2 = 2.0 Hz, 2H, CH2), 5.76 (dt, J1 = 10.0 Hz, J2 = 3.6 Hz, 1H, [double bond, length as m-dash]CH), 6.32 (s, 1H, [double bond, length as m-dash]CH), 6.40 (d, J = 10.0 Hz, 1H, [double bond, length as m-dash]CH), 6.79–6.84 (m, 2H, Ar), 7.01 (dd, J1 = 7.6 Hz, J2 = 2.4 Hz, 1H, Ar). 13C NMR (CDCl3, 100 MHz, TMS) δ 27.5, 29.9, 65.4, 120.6, 121.6, 122.1, 122.5, 124.6, 125.7, 126.4, 132.0, 142.5, 152.4. IR (neat) ν 3048, 2919, 2849, 1639, 1594, 1460, 1392, 1235, 1215, 1079, 1017, 927, 805, 750, 698 cm−1. MS (%) m/z 184 (M+, 100.00), 169 (42.04), 155 (56.12), 141 (30.97), 128 (47.38), 115 (50.82), 102 (15.29), 91 (23.72), 51 (22.85). HRMS (EI) calcd for C13H12O: 184.0888, found: 184.0892.

Acknowledgements

We are grateful for the financial support from the National Basic Research Program of China (973)-2015CB856603, and the National Natural Science Foundation of China (20472096, 21372241, 21361140350, 20672127, 21102166, 21121062, 21302203, 20732008 and 21572052).

Notes and references

  1. (a) W.-H. Chen, R. Wang and Y.-P. Shi, J. Nat. Prod., 2010, 73, 1398 CrossRef CAS PubMed; (b) I. N. Lykakis, C. Efe, C. Gryparis and M. Stratakis, Eur. J. Org. Chem., 2011, 12, 2334 CrossRef; (c) D. Z. Qiang, J. B. Shi, B. A. Song and X. H. Liu, RSC Adv., 2014, 4, 5607 RSC.
  2. (a) I. Iwai and T. Hiraoka, Chem. Pharm. Bull., 1963, 11, 638 CrossRef CAS; (b) I. Iwai and J. Ide, Chem. Pharm. Bull., 1963, 11, 1042 CrossRef CAS PubMed.
  3. (a) B. Martín-Matute, C. Nevado, D. J. Cárdenas and A. M. Echavarren, J. Am. Chem. Soc., 2003, 125, 5757 CrossRef PubMed; (b) S. J. Pastine, S. W. Youn and D. Sames, Org. Lett., 2003, 5, 1055 CrossRef CAS PubMed; (c) S. J. Pastine, S. W. Youn and D. Sames, Tetrahedron, 2003, 59, 8859 CrossRef CAS; (d) N. R. Curtis, J. C. Prodger, G. Rassias and A. J. Walker, Tetrahedron Lett., 2008, 49, 6279 CrossRef CAS; (e) G. Savitha, K. Felix and P. T. Perumal, Synlett, 2009, 13, 2079 Search PubMed; (f) W.-W. Qiu, K. Surendra, L. Yin and E. J. Corey, Org. Lett., 2011, 13, 5893 CrossRef CAS PubMed; (g) H. Zeng, J. Ju and R. Hua, Tetrahedron Lett., 2011, 52, 3926 CrossRef CAS; (h) D. Eom, J. Mo, P. H. Lee, Z. Gao and S. Kim, Eur. J. Org. Chem., 2013, 3, 533 CrossRef; (i) K. Surendra and E. J. Corey, J. Am. Chem. Soc., 2014, 136, 10918 CrossRef CAS PubMed; (j) H. Tinnermann, C. Wille and M. Alcarazo, Angew. Chem., Int. Ed., 2014, 53, 8732 CrossRef CAS PubMed; (k) H. Murase, K. Senda, M. Senoo, T. Hata and H. Urabe, Chem.–Eur. J., 2014, 20, 317 CrossRef CAS PubMed.
  4. (a) Z. Shi and C. He, J. Org. Chem., 2004, 69, 3669 CrossRef CAS PubMed; (b) C. Nevado and A. M. Echavarren, Chem.–Eur. J., 2005, 11, 3155 CrossRef CAS PubMed; (c) N. Mézailles, L. Ricard and F. Gagosz, Org. Lett., 2005, 7, 4133 CrossRef PubMed; (d) R. S. Menon, A. D. Findlay, A. C. Bissember and M. G. Banwell, J. Org. Chem., 2009, 74, 8901 CrossRef CAS PubMed; (e) C. Efe, I. N. Lykakis and M. Stratakis, Chem. Commun., 2011, 47, 803 RSC; (f) Y. Wang, K. Ji, S. Lan and L. Zhang, Angew. Chem., Int. Ed., 2012, 51, 1915 CrossRef CAS PubMed; (g) A. Arcadi, F. Blesi, S. Cacchi, G. Fabrizi, A. Goggiamani and F. Marinelli, Org. Biomol. Chem., 2012, 10, 9700 RSC; (h) P. Moran-Poladura, E. Rubio and J. M. Gonzalez, Beilstein J. Org. Chem., 2013, 9, 2120 CrossRef PubMed; (i) R. Nolla-Saltiel, E. Robles-Marín and S. Porcel, Tetrahedron Lett., 2014, 55, 4484 CrossRef CAS; (j) M. Kumar, G. B. Hammond and B. Xu, Org. Lett., 2014, 16, 3452 CrossRef CAS PubMed; (k) D. Malhotra, M. S. Mashuta, G. B. Hammond and B. Xu, Angew. Chem., Int. Ed., 2014, 53, 4456 CrossRef CAS PubMed.
  5. For selected reviews, see: (a) L. Yu and R. Guo, Org. Prep. Proced. Int., 2011, 43, 209 CrossRef CAS; (b) D.-H. Zhang, X.-Y. Tang and M. Shi, Acc. Chem. Res., 2014, 47, 913 CrossRef CAS PubMed; (c) A. Brandi, S. Cicchi, F. M. Cordero and A. Goti, Chem. Rev., 2014, 114, 7317 CrossRef CAS PubMed; (d) L. Yu, M. Liu, F. Chen and Q. Xu, Org. Biomol. Chem., 2015, 13, 8379 RSC.
  6. For recent contributions from our group and others, see: (a) A. I. Siriwardana, M. Kamada, I. Nakamura and Y. Yamamoto, J. Org. Chem., 2005, 70, 5932 CrossRef CAS PubMed; (b) M. Shi, L.-P. Liu and J. Tang, Org. Lett., 2006, 8, 4043 CrossRef CAS PubMed; (c) D. Takeuchi, A. Inoue, F. Ishimaru and K. Osakada, Macromolecules, 2008, 41, 6339 CrossRef CAS; (d) M. Jiang and M. Shi, Organometallics, 2009, 28, 5600 CrossRef CAS; (e) H. Taniguchi, T. Ohmura and M. Suginome, J. Am. Chem. Soc., 2009, 131, 11298 CrossRef CAS PubMed; (f) K. Ogata, Y. Atsuumi and S.-i. Fukuzawa, Org. Lett., 2010, 12, 4536 CrossRef CAS PubMed; (g) K. Chen, M. Jiang, Z. Zhang, W. Yin and M. Shi, Eur. J. Org. Chem., 2011, 35, 7189 CrossRef; (h) K. Ogata, D. Shimada, S. Furuya and S.-i. Fukuzawa, Org. Lett., 2013, 15, 1182 CrossRef CAS PubMed; (i) K. Chen, Z.-Z. Zhu, Y.-S. Zhang, X.-Y. Tang and M. Shi, Angew. Chem., Int. Ed., 2014, 53, 6645 CrossRef CAS PubMed; (j) T. Ohmura, H. Taniguchi and M. Suginome, ACS Catal., 2015, 5, 3074 CrossRef CAS; (k) Z. Zhu, K. Chen, Q. Xu and M. Shi, Adv. Synth. Catal., 2015, 357, 3081 CrossRef CAS; (l) Z.-Z. Zhu, K. Chen, L.-Z. Yu, X.-Y. Tang and M. Shi, Org. Lett., 2015, 17, 5994 CrossRef CAS PubMed; (m) K. Chen, Z.-Z. Zhu, J.-X. Liu, X.-Y. Tang, Y. Wei and M. Shi, Chem. Commun., 2016, 52, 350 RSC.
  7. For recent contributions from our group and others, see: (a) Y. Chen and M. Shi, J. Org. Chem., 2004, 69, 426 CrossRef CAS PubMed; (b) L.-X. Shao and M. Shi, Eur. J. Org. Chem., 2004, 2, 426 CrossRef; (c) M. Shi, B. Xu and J.-W. Huang, Org. Lett., 2004, 6, 1175 CrossRef CAS PubMed; (d) L.-X. Shao, B. Xu, J.-W. Huang and M. Shi, Chem.–Eur. J., 2006, 12, 510 CrossRef PubMedL.-X. Shao and M. Shi, Curr. Org. Chem., 2007, 11, 1135 CrossRef CAS; (e) Z.-B. Zhu, L.-P. Liu, L.-X. Shao and M. Shi, Synlett, 2007, 1, 115 Search PubMed; (f) M. Shi, M. Jiang and L.-P. Liu, Org. Biomol. Chem., 2007, 5, 438 RSC; (g) C. Taillier and M. Lautens, Org. Lett., 2007, 9, 591 CrossRef CAS PubMed; (h) B. Hu, S. Xing and Z. Wang, Org. Lett., 2008, 10, 5481 CrossRef CAS PubMed; (i) B. Hu, J. Zhu, S. Zing, J. Fang, D. Du and Z. Wang, Chem.–Eur. J., 2009, 15, 324 CrossRef CAS PubMed; (j) M. Jiang and M. Shi, Tetrahedron, 2009, 65, 5222 CrossRef CAS; (k) L. Yu, J. Meng, L. Xia and R. Guo, J. Org. Chem., 2009, 74, 5087 CrossRef CAS PubMed; (l) M. Jiang and M. Shi, Org. Lett., 2010, 12, 2606 CrossRef CAS PubMed; (m) X.-Y. Tang and M. Shi, Eur. J. Org. Chem., 2010, 21, 4106 CrossRef; (n) B. Hu, J. Ren and Z.-W. Wang, Tetrahedron, 2011, 67, 763 CrossRef CAS; (o) K. Chen, Z. Zhang, Y. Wei and M. Shi, Chem. Commun., 2012, 48, 7696 RSC; (p) M. Shi, J.-M. Lu, Y. Wei and L.-X. Shao, Acc. Chem. Res., 2012, 45, 641 CrossRef CAS PubMed; (q) K. Chen, R. Sun, Q. Xu, Y. Wei and M. Shi, Org. Biomol. Chem., 2013, 11, 3949 RSC; (r) R. Sun, D.-H. Zhang and M. Shi, Synlett, 2014, 25, 2293 CrossRef CAS.
  8. A. Fürstner and C. Aiessa, J. Am. Chem. Soc., 2006, 128, 6306 CrossRef PubMed.
  9. M. Shi, L.-P. Liu and J. Tang, J. Am. Chem. Soc., 2006, 128, 7430 CrossRef CAS PubMed.
  10. Y. Xu, M. L. Conner and M. K. Brown, Angew. Chem., Int. Ed., 2015, 54, 11918 CrossRef CAS PubMed.
  11. R. D. Bach and O. Dmitrenko, J. Am. Chem. Soc., 2006, 128, 4598 CrossRef CAS PubMed.
  12. (a) J. T. Zhang, H. Y. Wang, W. Zhu, T. T. Cai and Y. L. Guo, Anal. Chem., 2014, 86, 8937 CrossRef CAS PubMed; (b) D. Tang, Z. Chen, J. Zhang, Y. Tang and Z. Xu, Organometallics, 2014, 33, 6633 CrossRef CAS; (c) A.-M. Lorena, M. M. Martinez, L. A. Sarandeses and J. P. Sestelo, Org. Biomol. Chem., 2015, 13, 379 RSC.
  13. (a) A. Brown and G. H. Schmid, Can. J. Chem., 1972, 50, 2432 CrossRef CAS; (b) T. Sasaki, M. Ohno and T. Umemura, Chem. Lett., 1972, 503 CrossRef CAS; (c) E. Yurtsever, J. Moreshead and D. Shillady, Chem. Phys. Lett., 1975, 36, 365 CrossRef CAS; (d) R. D. Bowen, D. H. Williams, H. Schwarz and C. Wesdemiotis, J. Chem. Soc., Chem. Commun., 1979, 261 RSC; (e) M. Murakami and S. Nishida, Chem. Lett., 1981, 997 CrossRef CAS; (f) Y. Kusuyama, Bull. Chem. Soc. Jpn., 1998, 71, 685 CrossRef CAS; (g) F. Cacace, B. Chiavarino and M. E. Crestoni, Chem.–Eur. J., 2000, 6, 2024 CrossRef CAS PubMed; (h) A. E. Nadany and J. E. McKendrick, Tetrahedron Lett., 2007, 48, 4071 CrossRef CAS; (i) S. G. Sethofer, S. T. Staben, O. Y. Hung and F. D. Toste, Org. Lett., 2008, 10, 4315 CrossRef CAS PubMed; (j) T. Irshaidat, Tetrahedron Lett., 2008, 49, 5894 CrossRef CAS; (k) S. G. Sethofer, S. T. Staben, O. Y. Hung and F. D. Toste, Org. Lett., 2008, 10, 4315 CrossRef CAS PubMed; (l) M. Honda, T. Nishizawa, Y. Nishii, S. Fujinami and M. Segi, Tetrahedron, 2009, 65, 9403 CrossRef CAS; (m) M. Skvorcova, L. Grigorjeva and A. Jirgensons, Org. Lett., 2015, 17, 2902 CrossRef CAS PubMed; (n) M. Skvorcova, L. Grigorjeva and A. Jirgensons, Org. Lett., 2015, 17, 2902 CrossRef CAS PubMed.
  14. W. Wang, G. B. Hammond and B. Xu, J. Am. Chem. Soc., 2012, 134, 5697 CrossRef CAS PubMed.

Footnote

Electronic supplementary information (ESI) available: Experimental procedures, characterization data of new compounds. See DOI: 10.1039/c6ra02549h

This journal is © The Royal Society of Chemistry 2016
Click here to see how this site uses Cookies. View our privacy policy here.